# Syros Pharmaceuticals, Inc. (SYRS)

> 医疗保健 · US · 以 USD 报告

Sponda 的基本面指标，已按通胀调整。

[HTML 版本](https://sponda.capital/zh/SYRS/fundamentals)

## 年度数据

| 年份 | 营业收入 (M) | 净利润 (M) | FCF (M) | 债务 (M) | 股东权益 (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 0 | $ -35.14M | $ -85.61M | $ 60.23M | $ -11.12M |
| 2023 | $ 10.74M | $ -168.36M | $ -118.92M | $ 62.08M | $ 16.66M |
| 2022 | $ 11.36M | $ -58.43M | $ -138.86M | $ 63.57M | $ 127.74M |
| 2021 | $ 27.92M | $ -102.89M | $ -119.80M | $ 65.19M | $ 85.22M |
| 2020 | $ 19.23M | $ -107.06M | $ -77.33M | $ 66.21M | $ 90.55M |
| 2019 | $ 2.56M | $ -97.37M | $ -94.08M | $ 25.92M | $ 79.18M |
| 2018 | $ 2.71M | $ -82.25M | $ -55.07M | $ 31.0K | $ 78.59M |
| 2017 | $ 1.48M | $ -72.76M | $ -61.36M | $ 53.0K | $ 65.32M |
| 2016 | $ 436.1K | $ -65.69M | $ -58.97M | $ 221.0K | $ 80.60M |
| 2015 | $ 445.1K | $ -41.87M | $ -33.99M | $ 339.0K | $ 34.05M |
| 2014 | $ 0 | $ -6.82M | $ -4.97M | $ 0 | $ 60.24M |

此视图中不可用的列：annualPriceMultiples, dividends。它们需要实时市场数据，仅在 HTML 页面上显示。

## 杠杆与流动性

| 指标 | 数值 |
| --- | --- |
| 总债务 / 股东权益 | -5.41 |
| 总负债 / 股东权益 | -8.64 |
| 流动比率 | 2.25 |

## 其他视图

- [指标](https://sponda.capital/zh/SYRS.md)
- [图表](https://sponda.capital/zh/SYRS/charts.md)
- [对比](https://sponda.capital/zh/SYRS/compare.md)
- [指标定义](https://sponda.capital/zh/screener.md)

数据截至 2026-08-30。